Novo Nordisk slashes Wegovy price by nearly two-thirds for cash-paying patients
Novo Nordisk cut the price of its weight loss blockbuster Wegovy by nearly two-thirds for certain patients paying outside of insurance, following a similar move …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.